Eureka Genomics’ High-Throughput Sequencing and Bioinformatics Services Highlighted at “Now-Generation Sequencing” Conference

HERCULES, CA (March 16, 2010): Balancing high-throughput sequencing and related bioinformatics analysis between a research group’s internal efforts and specialized service providers can both speed results to difficult biological questions and provide cost-effective access to the latest technology, says Eureka Genomics (EG). The company’s unique capabilities and services and how they can help in “Finding the Right Balance” will be the topic of discussion at a “Java and Jive” session on Wednesday March 17, 8:15 am at the Now-Generation Sequencing conference being held at the Hilton San Diego Resort in San Diego, CA.

“We take pride in developing a consultive relationship with each and every client,” said Heather Koshinsky, Ph.D., Eureka Genomics’ Chief Scientific Officer. “As biologists ourselves, we understand that proper experimental design and library preparation all add to the quality of the sequencing. This, followed by application of the most appropriate bioinformatics tools, results in EG’s ability to solve our customers’ biggest genomics questions.” EG’s robust, proprietary and highly efficient algorithms use an “exact” model, avoiding a heuristic approximation approach, and together have yielded solutions to previously intractable biological problems.

“As a manufacturer of automated sample preparation instrumentation, IntegenX concentrates on reliability, reproducibility and full integration of applications. As we develop a NGS library preparation application, Eureka Genomics has provided IntegenX not only cost effective and timely results, but their bioinformatics capability let us know immediately the high quality of our automated NGS library preparations,” said Stevan Jovanovich, Ph.D., President and Chief Executive Officer of IntegenX.

Range of Services and Latest Technologies
Eureka Genomics offers a range of services, from library generation from a variety of samples types, to sequence data analysis and gene annotation. Cutting-edge technological capabilities developed in support of the company’s own discovery efforts are applied to its service customer’s everyday problems.

“This sets us apart from the competition,” Dr. Koshinsky continued. “We excel in both the “routine” and the “non-routine,” and thus can offer the complete solutions to our customers’ problems when needed, or can address the simplest request.” EG currently performs data generation with the Illumina GAIIx but plans to add access to other sequencing platforms based on its customers’ interests.

Expanding Services Globally
Building off the successful close of $3.7mil in financing last week, Eureka Genomics announced that some of this funding will be used to grow their service organization and to continue their goal for “Best in Breed” among the growing field of high-throughput sequencing and bioinformatics service providers. EG plans to grow its global sales and marketing and expand its service offerings into Europe and South East Asia.

About IntegenX
IntegenX, Inc. headquartered in Pleasanton, CA, is a privately-held company that designs, manufactures and markets automated DNA and RNA based sample preparation systems for life sciences, applied sciences, and diagnostics markets. The company’s products eliminate the most acute pain points affecting widely adopted laboratory workflows in genomics. Its first commercial product, the Apollo 100 System, is available today and integrates the company’s patented MOVe™ valve technology into a robotic platform that prepares DNA for cycle sequencing. Future IntegenX products will address next-generation sequencing library preparation and human DNA identification. The company’s expertise and intellectual property is based on a next-generation fluidics technology that integrates advanced microfluidics and analytical capabilities to produce sample-to-answer performance for DNA and RNA sequencing, DNA-based forensics and human identity (HID) testing, biodefense, as well as molecular diagnostics applications. For more details about IntegenX, its technologies and products can be found at www.integenx.com

About Eureka Genomics
Eureka Genomics is a privately held company and a leader in the advanced bioinformatics analysis of next-generation sequencing data. The company applies its capabilities to the discovery of novel microorganisms associated with cancers and other important diseases, as well as to providing cost-effective, rapid high-end sequencing and analysis services. Eureka Genomics current list of customers include numerous universities including the University of California at Davis and University of Houston, several National Laboratories, as well as biotechnology, pharmaceutical and cleantech companies and research institutions. Eureka Genomics is headquartered in Hercules, CA and has operations in Houston, TX. For more information on Eureka Genomics, please visit the company’s website at www.eurekagenomics.com.